Skip to main content

Table 3 Cytogenetic score groups based on R-IPSS

From: Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients

Cytogenetic prognosis subgroup Cytogenetic abnormality Total MDS subtypes
MDS-SLD MDS-MLD MDS-EB-1 MDS-EB-2 MDS with del (5q) MDS-RS MDS-U
Very good -y, del 11q 3 2
(7.1%)
1
(2.6%)
0 0 0 0 0
Good Normal 59 17 (60.7%) 22 (57.9%) 11 (73.3%) 5 (43.5%) 0 1 (33.3%) 3 (75%)
del5q, del20q 6 1
(3.5%)
1
(2.6%)
0 0 4 (100%) 0 0
Intermediate  + 8, + 19, del 7q, i(17q), other single/double abnormalities 26 8 (28.6%) 11 (28.9%) 3
(20%)
1
(9.1%)
0 2 (66.7%) 1 (25%)
Poor -7, inv (3), double including − 7/del(7q) and complex (3 abnormalities) 9 0 3
(7.9%)
1
(6.6%)
5 (45.5%) 0 0 0
Very poor  > 3 abnormalities 0 0 0 0 0 0 0 0